Skip to main content
SpringerLink
Log in
Book cover

Sports Cardiology Essentials pp 235–246Cite as

Management of Hypertension in Athletes

  • Chapter
  • First Online:

  • 1345 Accesses

Abstract

Athletes have a lower incidence of high blood pressure than nonathletes, but the prevalence of hypertension among athletes is only 50% less than that in the general population [1]. Further, the risk of hypertension may actually be increased in some athletes and physically active individuals because of increased body mass. Indeed, hypertension is the most common cardiovascular problem in athletes.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Lehmann M, Durr H, Merkelbach H, Schmid A. Hypertension and sports activities: institutional experience. Clin Cardiol 1990;13(3):197–208.

    Article  PubMed  CAS  Google Scholar 

  2. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003;42(6):1206–1252.

    Article  PubMed  CAS  Google Scholar 

  3. Pickering TG White coat hypertension. Curr Opin Nephrol Hypertens 1996;5(2):192–198.

    Article  PubMed  CAS  Google Scholar 

  4. Hanson P, Andrea BE. Treatment of hypertension in athletes. In:a DeLee J. Drez D. Starits ki CL, eds. Orthopaedic Sports Medicine: Principles and Practice. Philadelphia, Saunders, 1994:307–319.

    Google Scholar 

  5. Slovut DP, Olin JW. Fibromuscular dysplasia. N Engl J Med 2004;350(18):1862–1871.

    Article  PubMed  CAS  Google Scholar 

  6. Moore TA, Sorokin AV, Hirst C, Thornton-Thompson S, Thompson PD. The accuracy of aneroid sphygmomanometers in the ambulatory setting. Prev Cardiol 2008;11(2):90–94.

    Article  PubMed  Google Scholar 

  7. Samenuk D, Link MS, Homoud MK, Contreras R, Theoharides TC, Wang PJ et al. Adverse cardiovascular events temporally associated with ma huang, an herbal source of ephedrine. Mayo Clin Proc 2002;77(1):12–16.

    Article  PubMed  Google Scholar 

  8. Sacks FM, Svetkey LP, Vollmer WM, Appel LJ, Bray GA, Harsha D et al. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med 2001;344(1):3–10.

    Article  PubMed  CAS  Google Scholar 

  9. Vollmer WM, Sacks FM, Ard J, Appel LJ, Bray GA, Simons-Morton DG et al. Effects of diet and sodium intake on blood pressure: subgroup analysis of the DASH-sodium trial. Ann Intern Med 2001;135(12):1019–1028.

    PubMed  CAS  Google Scholar 

  10. USADA guide to prohibited classes of substances and prohibited methods of doping. www. 2008. 10-3-2001.

  11. Fuentes RJ, Rosenberg JM. Athletic drug reference “99: complies with NCAA and USOC rules. Clean Data. Durhan, NC, Glaxco Wellcome. 2008:28–36, 52–54, 317–408.

    Google Scholar 

  12. IOC prohibited classes of substances and prohibited methods of doping. 10-2-2001.

    Google Scholar 

  13. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991;265(24):3255–3264.

    Google Scholar 

  14. Curb JD, Pressel SL, Cutler JA, Savage PJ, Applegate WB, Black H et al. Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group. JAMA 1996;276(23):1886–1892.

    Article  PubMed  CAS  Google Scholar 

  15. Philipp T, Anlauf M, Distler A, Holzgreve H, Michaelis J, Wellek S. Randomised, double blind, multicentre comparison of hydrochlorothiazide, atenolol, nitrendipine, and enalapril in antihypertensive treatment: results of the HANE study. HANE Trial Research Group. BMJ 1997;315(7101):154–159.

    Article  PubMed  CAS  Google Scholar 

  16. Amery A, Birkenhager W, Brixko P, Bulpitt C, Clement D, Deruyttere M et al. Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly trial. Lancet 1985;1(8442):1349–1354.

    Article  PubMed  CAS  Google Scholar 

  17. Dahlof B, Lindholm LH, Hansson L, Schersten B, Ekbom T, Wester PO. Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension). Lancet 1991;338(8778):1281–1285.

    Article  PubMed  CAS  Google Scholar 

  18. Nussberger J, Cugno M, Cicardi M. Bradykinin-mediated angioedema. N Engl J Med 2002;347(8):621–622.

    Article  PubMed  Google Scholar 

  19. Martin U, Foreman MA, Travis JC, Casson D, Coleman JJ (2008) Use of ACE inhibitors and ARBs in hypertensive women of childbearing age. J Clin Pharm Ther 33(5):507–511.

    Article  PubMed  CAS  Google Scholar 

  20. Chick TW, Halperin AK, Gacek EM. The effect of antihypertensive medications on exercise performance: a review. Med Sci Sports Exerc 1988;20(5):447–454.

    PubMed  CAS  Google Scholar 

  21. ALLHAT Collaborative Research Group. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). JAMA 2000;283(15):1967–1975.

    Google Scholar 

  22. Kaplan NM, Gidding SS, Pickering TG, Wright JT Jr. Task Force 5: systemic hypertension. J Am Coll Cardiol 2005;45(8):1346–1348.

    Article  PubMed  Google Scholar 

  23. Pickering TG. Measurement of blood pressure in and out of the office. J Clin Hypertens (Greenwich) 2005;7(2):123–129.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Cardiovascular Services Hospitalist, Hartford Hospital, Hartford, CT, USA

    Shafeeq Ahmed

Authors
  1. Shafeeq Ahmed
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Paul D. Thompson
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Shafeeq Ahmed .

Editor information

Editors and Affiliations

  1. Sports Cardiology Consultants, LLC, Chicago, 60654, Illinois, USA

    Christine E. Lawless

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Ahmed, S., Thompson, P.D. (2011). Management of Hypertension in Athletes. In: Lawless, C. (eds) Sports Cardiology Essentials. Springer, New York, NY. https://doi.org/10.1007/978-0-387-92775-6_12

Download citation

  • DOI: https://doi.org/10.1007/978-0-387-92775-6_12

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-0-387-92774-9

  • Online ISBN: 978-0-387-92775-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation